The Bridge2AI-Voice Consortium, a program based on the NIH-funded study called Voice as a Biomarker of Health that is co-led by experts from Weill Cornell Medicine’s Englander Institute for Precision Medicine (EIPM) and the USF Health...
Read more
Surgery that removes only a portion of one of the five lobes that comprise a lung is as effective as the traditional surgery that removes an entire lobe for certain patients with early-stage lung cancer, according to results of a phase 3...
Read more
A protein commonly found at high levels in lung cancer cells controls a major immunosuppressive pathway that allows lung tumors to evade immune attack, according to a study led by researchers at Weill Cornell Medicine. The discovery could hasten...
Read moreThe following article first appeared in the Weill Cornell Medicine Newsroom on November 21st and features a number of EIPM Members including Drs. Nasser Altorki, Olivier Elemento, Vivek Mittal, Niroshana Anandasabapathy, and Karla Ballman. ...
Read more